Literature DB >> 10827118

High prevalence of penicillin-nonsusceptible Streptococcus pneumoniae at a community hospital in Oklahoma.

R L Moolenaar1, R Pasley-Shaw, J R Harkess, A Lee, J M Crutcher.   

Abstract

During 1997, Oklahoma City's Hospital A reported penicillin-nonsusceptible Streptococcus pneumoniae in almost 67% of isolates. To confirm this finding, all Hospital A S. pneumoniae isolates from October 23, 1997, through February 19, 1998, were tested for antibiotic susceptibility and repeat-tested at two other hospital laboratories. Medical records of Hospital A patients with invasive S. pneumoniae infections during 1994 through 1997 were also reviewed. These data were compared with 1998 statewide sentinel hospital surveillance data for invasive S. pneumoniae. Of 48 S. pneumoniae isolates from Hospital A during October 23, 1997, through February 19, 1998, 31 (65%) were penicillin-nonsusceptible S. pneumoniae, and 23 (48%) were highly penicillin resistant. Similar prevalences were confirmed at the other hospital laboratories; however, significant interlaboratory differences were noted in the determination of third-generation cephalosporin susceptibility. During 1994 through 1997, a trend toward increasing penicillin nonsusceptibility (p <0.05) was noted among S. pneumoniae isolates from nursing home patients. During 1998, 85 (30%) of 282 invasive isolates reported to the state surveillance system were penicillin-nonsusceptible S. pneumoniae; 33 (12%) were highly resistant. The increase in resistance observed is notable; the interlaboratory discrepancies are unexplained. To respond, a vaccination program was implemented at Hospital A, and vaccination efforts were initiated at nursing homes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10827118      PMCID: PMC2640867          DOI: 10.3201/eid0603.000308

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


  21 in total

1.  Adult immunization programs in nontraditional settings: quality standards and guidance for program evaluation.

Authors:  A S Postema; R F Breiman
Journal:  MMWR Recomm Rep       Date:  2000-03-24

Review 2.  Pneumococcal drug resistance: the new "special enemy of old age".

Authors:  J C Butler; M S Cetron
Journal:  Clin Infect Dis       Date:  1999-04       Impact factor: 9.079

3.  Evaluation of commercial methods for determining antimicrobial susceptibility of Streptococcus pneumoniae.

Authors:  F C Tenover; C N Baker; J M Swenson
Journal:  J Clin Microbiol       Date:  1996-01       Impact factor: 5.948

Review 4.  Evaluation of the effectiveness of immunization delivery methods.

Authors:  T W Gyorkos; T N Tannenbaum; M Abrahamowicz; L Bédard; J Carsley; E D Franco; G Delage; M A Miller; D L Lamping; S A Grover
Journal:  Can J Public Health       Date:  1994 Jul-Aug

5.  Emergence of drug-resistant pneumococcal infections in the United States.

Authors:  R F Breiman; J C Butler; F C Tenover; J A Elliott; R R Facklam
Journal:  JAMA       Date:  1994-06-15       Impact factor: 56.272

6.  Invasive disease due to Streptococcus pneumoniae in an area with a high rate of relative penicillin resistance.

Authors:  G R Istre; M Tarpay; M Anderson; A Pryor; D Welch
Journal:  J Infect Dis       Date:  1987-11       Impact factor: 5.226

7.  Comparison of E test with standard broth microdilution for determining antibiotic susceptibilities of penicillin-resistant strains of Streptococcus pneumoniae.

Authors:  E A Macias; E O Mason; H Y Ocera; M T LaRocco
Journal:  J Clin Microbiol       Date:  1994-02       Impact factor: 5.948

8.  Minimizing the impact of drug-resistant Streptococcus pneumoniae (DRSP). A strategy from the DRSP Working Group.

Authors:  D B Jernigan; M S Cetron; R F Breiman
Journal:  JAMA       Date:  1996-01-17       Impact factor: 56.272

9.  Invasive pneumococcal disease in central Oklahoma: emergence of high-level penicillin resistance and multiple antibiotic resistance. Pneumococcus Study Group.

Authors:  L A Haglund; G R Istre; D A Pickett; D F Welch; D P Fine
Journal:  J Infect Dis       Date:  1993-12       Impact factor: 5.226

10.  The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta.

Authors:  J Hofmann; M S Cetron; M M Farley; W S Baughman; R R Facklam; J A Elliott; K A Deaver; R F Breiman
Journal:  N Engl J Med       Date:  1995-08-24       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.